CDC Updates COVID Vaccine Recommendations for Older Adults (SNF/AL)

On October 23, the Centers for Disease Control (CDC) recommended that people 65 years and older and those who are moderately or severely immunocompromised receive a second dose of the 2024-2025 COVID-19 vaccine six months after their first dose. These updated recommendations also allow for flexibility for additional doses (i.e., three or more) for those who are moderately or severely immunocompromised, in consultation with their healthcare provider. The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults and those who are immunocompromised, along with the currently available data on vaccine effectiveness and year-round circulation of COVID-19. The recommendation also provides clarity to healthcare providers on how many doses should be given per year to people who are moderately or severely immunocompromised and is meant to increase coverage of a second dose for that group.